Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 14-12-2024 12:30:26
GD LIFE - A3
No. Investigation Observed Value Unit Biological Ref. Interval
Complete Haemogram Test
Erythrocytes
1 Total Red Blood Cell Count (RBC) 0.49 10^6/µL 4.1-6
2 Hemoglobin 1.1 g/dL 13 -17.5
3 Hematocrit (PCV) 4.0 % 33-57
4 Mean Corpuscular Volume (MCV) 82.0 fL 80-96
5 Mean Corpuscular Hemoglobin (MCH) 22.0 pg 27.5-33.2
6 Mean Corpuscular Hemoglobin Concentration 32.1 g/dL 30.4-34.5
(MCHC)
7 Red Cell Distribution Width (RDW-CV) 16.5 % 12-15
8 Red Cell Distribution Width-SD(RDW-SD) 51.1 fl 30-64.5
9 Nucleated Red Blood Cells 0.0 cells/µL 0 - 1.36
10 Nucleated Red Blood Cells Percentage 0.0 % 0-4
Platelets
11 Platelet Count 90.0 10^3/µL 150-450
12 Mean Platelet Volume (MPV) 11.47 fL 6 - 12
13 Platelet Distribution Width (PDW) 11.4 % 15.5-18.3
14 Plateletcrit (PCT) 0.03 % 0.12-0.37
Leucocytes
15 Total Leucocytes Count 1.0 10^3/µL 4.4-11
16 Neutrophils 62.0 % 40-77
17 Lymphocyte Percentage 32.0 % 16-44
18 Monocytes Percentage 4.0 % 2.0-10.0
19 Eosinophils Percentage 2.0 % 0-7
20 Basophils Percentage 0.0 % 0-1
21 Neutrophils-Absolute Count 0.62 10^3/µL 1.8-7.8
22 Lymphocytes-Absolute Count 0.32 10^3/µL 1-4.8
23 Monocytes-Absolute Count 0.04 10^3/µL 0.1-1.0
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:30
Report Time: 14-12-2024 12:30 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 1 of 2
Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 14-12-2024 12:30:26
GD LIFE - A3
No. Investigation Observed Value Unit Biological Ref. Interval
Leucocytes
24 Eosinophils-Absolute Count 0.02 10^3/µL 0 - 0.45
25 Basophils-Absolute Count 0.00 10^3/µL 0-0.2
Peripheral Blood Smear
26 RBC Morphology See Remark
27 WBC Morphology Leucopenia
28 Platelets Reduced On
Smear
Remarks
RBC:- Normocytic normochromic anisopoikilocytosis spherocytes polychromatic cells.
Reduced in number
Impression:- Pancytopenia
Advice:- LFT, RFT, COOMBS TEST, Vitb12 and Folic acid test, Reticulocytes count, LDH.
*Rechecked kindly correlate clinically.
Interpretation
Sample type: EDTA whole blood.
Test Methods:
RBC/WBC/Platelets: Impedance method,
Hemoglobin: Photometric measurement,
Differential count: VCSn Technology,
MCV, MPV: Measured parameter Indices,
Absolute counts: Calculated.
(Processed on Fully Automated 5 parts differential Hematology analyzer).
End Of Report
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:30
Report Time: 14-12-2024 12:30 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 2 of 2
Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 13-12-2024 22:05:02
GD LIFE - A3
No. Investigation Observed Value Unit Biological Reference Interval
Liver Function Test
1 Bilirubin Total 1.25 mg/ dL 0.2-1.2
Serum, Method: Jendrassik Grof
2 Bilirubin Direct 0.35 mg/ dL 0.01 - 0.4
Serum, Method: Diazotization
3 Bilirubin Indirect 0.9 mg/dL 0.01-1.0
Serum, Method: Calculated
4 Aspartate Transaminase (AST/SGOT) 39.0 U/ L <50
Serum, Method: IFCC without P5P
5 Alanine Transaminase (ALT/SGPT) 26.0 U/ L <50
Serum, Method: IFCC without P5P
6 Alkaline Phosphatase 94.0 U/L 30 - 130
Serum, Method: AMP – pNPP Kinetic
7 Total Protein 7.1 g/dL 6.4 - 8.2
Serum, Method: Biuret end point
8 Albumin 3.6 g/dL 3.4 - 5
Serum, Method: Bromocresol Purple (BCP)
9 Globulin 3.5 g/dL 1.9-3.9
Serum, Method: Calculated
10 A/G ratio 1.03 Ratio 1.0 - 2.0
Serum, Method: Calculated
11 Gamma GT 46.0 U/L 5 - 85
Serum, Method: G glutamyl carboxy nitroanilide
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:50
Report Time: 13-12-2024 22:05 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 1 of 4
Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 13-12-2024 22:05:02
GD LIFE - A3
No. Investigation Observed Value Unit Biological Reference Interval
Kidney Profile
1 BUN (Blood Urea Nitrogen) 11.78 mg/dL 3.3 - 18.7
Serum, Method: Calculated
2 Creatinine 1.12 mg/dL 0.5 - 1.3
Serum, Method: Alkaline picrate kinetic
3 Urea 25.2 mg/dL 7 - 40
Serum, Method: Urease-GLDH
4 BUN/Creatinine ratio 10.52 4.0 - 21.5
Serum, Method: Calculated
5 Uric Acid 6.04 mg/ dL 2.1 - 7.5
Serum, Method: Uricase, UV
6 Calcium 8.92 mg/dL 8.5 - 10.5
Serum, Method: O cresolphthalein complexone
7 eGFR (estimated Glomerular Filtration Rate) 70.67 mL/min/1.73 m² Normal: > 90
Serum, Method: Calculated (MDRD formula) Mild decrease in GFR: 60- 89
Moderate decrease in GFR: 30-59
Severe decrease in GFR: 15-29
Kidney failure: < 15
Interpretation
A renal function panel could be ordered when a patient has risk factors for kidney dysfunction such as high blood pressure
(hypertension), diabetes, cardiovascular disease, obesity, elevated cholesterol, or a family history of kidney disease. A renal
function panel may also be ordered when someone has signs and symptoms of kidney disease, though early kidney disease often
does not cause any noticeable symptoms. It may be initially detected through routine blood or urine testing. Renal function panel
results are not diagnostic but rather indicate that there may be a problem with the kidneys and that further testing is required to
make a diagnosis and determine the cause. Results of the panel are usually considered together, rather than separately.
Individual test result can be abnormal due to causes other than kidney disease, but taken together with risks and signs and
symptoms, they may give an indication of whether kidney disease is present.
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:50
Report Time: 13-12-2024 22:05 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 2 of 4
Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 13-12-2024 22:05:02
GD LIFE - A3
No. Investigation Observed Value Unit Biological Reference Interval
Lipid Profile
1 Total Cholesterol 102.0 mg/dL Desirable: <200;
Serum, Method: Cholesterol Borderline high = 200-239;
oxidase,esterase,peroxidase High: > 240
2 Triglycerides 68.0 mg/dL Desirable: <150
Serum, Method: Enzymatic, end point GPO-POD Borderline High: 150 - 199
High: > 200 - 499
3 HDL-Cholesterol 39.1 mg/dL 30 - 60
Serum, Method: Enzymatic Immunoinhibition
4 LDL- Cholesterol 49.30 mg/dL Optimal: <100;
Serum, Method: Calculated Near Optimal: 100-129;
Borderline High: 130-159;
High: 160-189;
Very high: >190
5 Cholesterol/HDL ratio 2.61 Optimal: <3.5
Serum, Method: Calculated Near Optimal: 3.5 - 5.0
High >5.0
6 VLDL Cholesterol 13.60 mg/dL 6 - 40
Serum, Method: Calculated
7 Non HDL Cholesterol 62.90 mg/dl Desirable: <130
Serum, Method: Calculated Borderline high: 130-159
High : 160-189
Very High :>190
8 LDL /HDL ratio 1.26 Optimal: <2.5
Serum, Method: Calculated Near Optimal: 2.5-3.5
High >3.5
Interpretation
1.Triglycerides: When triglycerides are very high greater than 1000 mg/dL, there is a risk of developing pancreatitis in children
and adults. Triglycerides change dramatically in response to meals, increasing as much as 5 to 10 times higher than fasting
levels just a few hours after eating. Even fasting levels vary considerably day to day. Therefore, modest changes in fasting
triglycerides measured on different days are not considered to be abnormal.
2. HDL-Cholesterol: HDL- C is considered to be beneficial, the so-called "good" cholesterol, because it removes excess
cholesterol from tissues and carries it to the liver for disposal. If HDL-C is less than 40 mg/dL for men and less than 50 mg/dL
for women, there is an increased risk of heart disease that is independent of other risk factors, including the LDL-C level. The
NCEP guidelines suggest that an HDL cholesterol value greater than 60 mg/dL is protective and should be treated as a negative
risk factor.
3. LDL-Cholesterol: Desired goals for LDL-C levels change based on individual risk factors. For young adults, less than 120
mg/dL is acceptable. Values between 120-159 mg/dL are considered Borderline high. Values greater than 160 mg/dL are
considered high. Low levels of LDL cholesterol may be seen in people with an inherited lipoprotein deficiency and in people
with hyperthyroidism, infection, inflammation, or cirrhosis.
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:50
Report Time: 13-12-2024 22:05 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 3 of 4
Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 13-12-2024 22:05:02
GD LIFE - A3
No. Investigation Observed Value Unit Biological Reference Interval
1 TSH (Thyroid Stimulating Hormone) 5.302 µIU/ml 0.35 - 5.5
Serum, Method: CLIA
Interpretation
1. Conditions associated with increases in TSH include congenital hypothyroidism, primary hypothyroidism, TSH-secreting
pituitary tumors (uncommon), Pituitary resistance to thyroid hormone (uncommon), drugs like dopamine.
2. TSH levels may be seen low in Hyperthyroidism, Pituitary (secondary) hypothyroidism (rare), Nonthyroid illness, drugs.
Age Group Reference range (µIU/ml)
0 - 7 Days 2.1 - 20.0
8 Days - 1 Month 1.1 - 17.1
2 Month - 5 Years 0.4 - 8.6
6 Years - 18 Years 0.36 - 5.9
19 Years above 0.35 - 5.5
First trimester 0.05 - 3.7
Second trimester 0.31 - 4.35
Third trimester 0.41 - 5.18
End Of Report
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:50
Report Time: 13-12-2024 22:05 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 4 of 4
Name: RAVINDER PRASAD Age/Gender: 70 Years/Male
0000009391546
SAI DIAGNOSTIC COLLECTION
Referred By: A . HAIDREE Client Name:
CENTRE
Collection Date: 13-12-2024 10:37:00 Report Release Date: 14-12-2024 12:30:26
GD LIFE - A3
Pending Test Data
Sr.No Test Name Sample Id Status
1 Glucose (Fasting) CCP2093915461 Pending
CRM No :9391546
Sample Recd. Time: 13-12-2024 16:30
Report Time: 14-12-2024 12:30 Authorized Signatory
Patient Name: RAVINDER PRASAD Dr. Prerna Choudhary
Patient ID: 9391546 MBBS,MD (Pathology)
Scan For Report Scan To Verify
Page 1 of 1
QUALITY POLICY
GENERAL DIAGNOSTICS INTERNATIONAL (P) Ltd. maintains the highest standards of quality control in all aspects
of laboratory work. The purpose of our laboratory’s Quality Management System is to ensure that:
Principles of all accreditations, including that of NABL - ISO1518:2012 (National Accreditation Board of Laboratories) are adhered
for each test in the scope of the accreditation, and beyond.
Test methods, processes and control mechanisms are timely updated and fully validated to ensure the accuracy and
reliability of our test results.
The objectives of our Quality Control system are:
Use Bar-Coded operations to enable full traceability throughout the sample flow process and to ensure sample handling
procedures and environmental conditions are managed well and there is no or minimal affect on the results.
Continually improve the practices of our clients, franchise partners, associate doctors, clinics and hospitals and monitor their
training needs. Be proactive in identifying gaps in the processes being followed. Guide them to ensure that the patients are
served in the best possible way.
Report the results with accuracy and clarity in a timely manner. Do a root cause analysis whenever there is a deviation against
protocols and find solutions to the identified causes.
Ensure a continual enhancement, implementation and maintenance of the quality system and seek improvement in the
effectiveness of the quality system from experts at regular intervals.
Meet and exceed expectations with respect to turn-around time, sample collection hygiene & reliability of service.
Ensure that each test is performed by qualified and trained staff. Provide opportunities to the staff so that they can increase
their knowledge and use the same for self and organizational betterment.
Ensure that the equipment used are best in class, properly maintained and calibrated and where possible, measurements are
traceable to recognized standards. Also explore methods which may lead to improvement in equipment performance and
methodologies used for conducting tests.
Enable technology upgrades to achieve higher accuracy and reduced complexities.
Use internal audits and other checks to ensure the quality system complies with requirements; ensure problems are
investigated promptly, root cause(s) established and effective action taken to prevent a recurrence.
Have a smooth communication mechanism to ensure information is made available as rapidly as possible to those who need
it, both internal and external to the organization.
Monitor, help and support our franchise and service partners to be sensitive on all aspects of service delivery and to ensure
quality standards are followed with no exceptions.
CONDITIONS of REPORTING
01. It is presumed that the specimen accompanying the TRF (Test Requisition Form where 07. For certain category of tests, the report may carry a “PRELIMINARY” status implying
the details of patient are recorded) is of the same patient whose details are there in the that the results are yet to be reported for one (or more) tests. For example, in the case
TRF. with certain microbiology tests, a “FINAL” culture, identification or drug susceptibility
02. A test requested might not be performed due to the following reasons(s): result might be pending. In such case, the status “RESULT PENDING” will be mentioned
2.1 Insufficient quantity of specimen required to conduct the test. on report. The same shall be replaced by the test results whenever it is ready.
2.2 Poor quality of the Specimen not meeting the quality criteria 08. If the collection date or any other details was not stated in the Test Requisition Form,
(hemolysis of sample/clotted.) the same will not be printed on the report. In cases where the missing information is
2.3 Incorrect specimen type as required to conduct a test. mandatory for report generation or meeting accreditation guidelines, the sample
03. Test(s) may be patly or fully cancelled due to incorrect test code, incorrect name of the shall not be processed at all.
test or incorrect type of specimen. A communication shall be made and it is expected 09. Tests parameters excluded from the “scope” of NABL accreditation shall be marked
that a fresh specimen will be sent to laboratory for analysis of same parameter(s). by asterisks.
04. The results of laboratory investigation are dependent on the quality of the specimen as 10. In case you are not the intended recipient of the report, please immediately inform
well as the assay procedures/technologies used. All samples collected for tests are the same to the issuing entity. Any use, disclosure, copy or distribution of any
required to be prepared, stored, labeled and brought to processing laboratory as per the contents of such report, is unlawful and is strictly prohibited.
prescribed guidelines of GENERAL DIAGNOSTICS. 11. Some test may be referred to other laboratories to provide a wider test menu to the
05. GENERAL DIAGNOSTICS laboratory cannot be held liable for incorrect results of a sample patients. The details of the laboratory where the sample was referred to, can be
which deviated from the guidelines issued. obtained from Customer Care department.
06. There can be several factors like sample’s unintended exposure to heat or travel through 12. Claims of comparing results against that from a different laboratory shall be looked
rough terrain which affect the quality of test results. Therefore a 2% chance of error/ into only if it was the same sample which was split and sent in same conditions to all
deviation in results is a possibility. laboratories and processed on the same technology.
इस का मूल आधार है “बेटी”
माता पता ही नह , देश का स ान है “बेटी” बेटी बचाओ बे पढ़ाओ
GENERAL DIAGNOSTICS INTERNATIONAL (P) LTD., Plot - 06, Sector-24, Turbhe, Navi Mumbai, Maharashtra, India - 400 705.
022 - 4045 0000 / +91 98717 15111
[email protected] www.gd-lab.com
